Biopharmaceutical production technology

UPSTREAM TECHNOLOGIES Strategies for Plasmid DNA Production in Escherichia coli Advances in Protein Production Technologies PROTEIN RECOVERY Releasing Biopharmaceutical Products from Cells Continuous Chromatography (Multicolumn Countercurrent Solvent Gradient Purification) for Protein Purification Virus-Like Particle Bioprocessing Therapeutic Protein Stability and Formulation Production of PEGylated Proteins ADVANCES IN PROCESS DEVELOPMENT Affinity Chromatography: Historical and Prospective Overview Hydroxyapatite in Bioprocessing Monoliths in Bioprocessing Membrane Chromatography for Biopharmaceutical Manufacturing Modeling and Experimental Model Parameter Determination with Quality by Design for Bioprocesses ANALYTICAL TECHNOLOGIES Biosensors in the Processing and Analysis of Biopharmaceuticals Proteomics Toolkit: Applications in Protein Biological Production and Method Development Science of Proteomics: Historical Perspectives and Possible Role in Human Healthcare QUALITY CONTROL Consistency of Scale-Up from Bioprocess Development to Production Systematic Approach to Optimization and Comparability of Biopharmaceutical Glycosylation Throughout the Drug Life Cycle Quality and Risk Management in Ensuring the Virus Safety of Biopharmaceuticals Ensuring Quality and Efficiency of Bioprocesses by the Tailored Application of Process Analytical Technology and Quality by Design PROCESS DESIGN AND MANAGEMENT Bioprocess Design and Production Technology for the Future Integrated Process Design: Characterization of Process and Product Definition of Design Spaces Evaluating and Visualizing the Cost-Effectiveness and Robustness of Biopharmaceutical Manufacturing Strategies CHANGING FACE OF PROCESSING Full Plastics: Consequent Evolution in Pharmaceutical Biomanufacturing from Vial to Warehouse BioSMB Technology: Continuous Countercurrent Chromatography Enabling a Fully Disposable Process Single-Use Technology: Opportunities in Biopharmaceutical Processes Single-Use Biotechnologies and Modular Manufacturing Environments Invite Paradigm Shifts in Bioprocess Development and Biopharmaceutical Manufacturing